Lung vessels are unique in the body in that they react to hypoxia with constriction rather than dilatation. Whether this characteristic is inherent in the lung vessel or is due to an influence from a sensor in the surrounding lung parenchyma is not resolved. Recent data, however, showing that vascular hypoxia as well as airway hypoxia can produce pulmonary vasoconstriction and that the sensor for alveolar hypoxia is upstream in the precapillary vessels, allows but does not prove the precapillary pulmonary artery itself to be the O2 sensor. In addition, with the elimination of the mast cell as a necessary extravascular sensor for hypoxia at least in the mouse, there is no good candidate for an extravascular sensor for hypoxic pulmonary vasoconstriction.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1378/chest.88.4_supplement.235s | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Proof of concept study - alternative pharmacoprophylaxis for high-altitude pulmonary edema: A hospital-based randomized controlled trial.
Med J Armed Forces India
October 2023
Medical Specialist, 159 General Hospital, C/o 56 APO, India.
Background: High-altitude pulmonary edema (HAPE) is noncardiogenic pulmonary edema caused by exaggerated hypoxic pulmonary vasoconstriction and abnormally high pulmonary artery pressure. Some patients who develop HAPE have more chances to develop HAPE again on reinduction to high altitude (HA). This was a pilot project to look for a suitable drug (acetazolamide, nifedipine, or tadalafil) that could be used prophylactically in HAPE patients on reinduction to HA.
View Article and Find Full Text PDFPathophysiology of Group 3 Pulmonary Hypertension Associated with Lung Diseases and/or Hypoxia.
Int J Mol Sci
January 2025
Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Pulmonary hypertension associated with lung diseases and/or hypoxia is classified as group 3 in the clinical classification of pulmonary hypertension. The efficacy of existing selective pulmonary vasodilators for group 3 pulmonary hypertension is still unknown, and it is currently associated with a poor prognosis. The mechanisms by which pulmonary hypertension occurs include hypoxic pulmonary vasoconstriction, pulmonary vascular remodeling, a decrease in pulmonary vascular beds, endothelial dysfunction, endothelial-to-mesenchymal transition, mitochondrial dysfunction, oxidative stress, hypoxia-inducible factors (HIFs), inflammation, microRNA, and genetic predisposition.
View Article and Find Full Text PDFMicrovessels-on-chip: Exploring endothelial cells and COVID-19 plasma interaction with nitric oxide metabolites.
Nitric Oxide
January 2025
Division of Systems Biomedicine and Pharmacology, LACDR, Leiden University, the Netherlands.
COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), primarily manifests as a flu-like illness with lung injury, often necessitating supplemental oxygen. Elderly individuals and those with pre-existing cardiovascular diseases are at increased risk of mortality. The endothelial barrier disruption observed in patients indicates systemic viral invasion and widespread endotheliitis.
View Article and Find Full Text PDFEffects of ultrasound-guided stellate ganglion block on intrapulmonary shunt and oxygenation in patients with single-lung ventilation.
Front Surg
December 2024
Department of Anesthesiology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China.
Background: Single-lung ventilation (SLV) is a widely used procedure in thoracic surgery; however, it can lead to hypoxemia, which is attributed to intrapulmonary shunt and hypoxic pulmonary vasoconstriction. Stellate ganglion blockade (SGB) has shown protective effects during SLV in various pulmonary conditions. The objective of the study was to assess the clinical utility of ultrasound-guided SGB in patients undergoing thoracoscopic pulmonary lobectomy through a prospective clinical trial.
View Article and Find Full Text PDFThe impact of oral contraceptive pill use on sympathetic transduction at rest in young females.
Am J Physiol Heart Circ Physiol
February 2025
Neurovascular Research Laboratory, School of Kinesiology, Western University, London, Ontario, Canada.
Although previous work has demonstrated that oral contraceptive pill (OCP) use does not affect resting muscle sympathetic nerve activity (MSNA), growing evidence indicates that it attenuates neurogenic vasoconstriction. Despite these advances, it remains unknown how OCP use affects the ability of MSNA to dynamically control vascular tone and arterial blood pressure (BP) on a beat-by-beat basis. Thus, we tested the hypothesis that, compared with naturally menstruating females (MC), those using OCPs will exhibit attenuated sympathetic vascular transduction at rest.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!